评测大模型对药物机制的理解与推理能力，发现小模型也能媲美大模型。

Two scientific fields showing increasing interest in pre-trained large language models (LLMs) are drug development / repurposing, and personalized medicine. For both, LLMs have to demonstrate factual knowledge as well as a deep understanding of drug mechanisms, so they can recall and reason about relevant knowledge in novel situations. Drug mechanisms of action are described as a series of interactions between biomedical entities, which interlink into one or more chains directed from the drug to the targeted disease. Composing the effects of the interactions in a candidate chain leads to an inference about whether the drug might be useful or not for that disease. We introduce a dataset that evaluates LLMs on both factual knowledge of known mechanisms, and their ability to reason about them under novel situations, presented as counterfactuals that the models are unlikely to have seen during training. Using this dataset, we show that o4-mini outperforms the 4o, o3, and o3-mini models from OpenAI, and the recent small Qwen3-4B-thinking model closely matches o4-mini's performance, even outperforming it in some cases. We demonstrate that the open world setting for reasoning tasks, which requires the model to recall relevant knowledge, is more challenging than the closed world setting where the needed factual knowledge is provided. We also show that counterfactuals affecting internal links in the reasoning chain present a much harder task than those affecting a link from the drug mentioned in the prompt.